In the latest meeting minutes released by the US Food and Drug Administration (FDA), the agency noted that significant ...
The US Food and Drug Administration (FDA) has announced that starting on 1 October 2026, manufacturers must submit adverse ...
The US Food and Drug Administration (FDA) has submitted its budget proposal to Congress, outlining its spending priorities ...
In the latest tranche of published warning letters, the US Food and Drug Administration (FDA) has continued to go after ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
Join RAPS Greater Cincinnati for a volunteer networking event at Matthew 25 Ministries. Help process donated goods while ...
Several patient and disease advocacy organizations have responded to the Center for Drug Evaluation and Research's (CDER) ...
AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion ( STAT) AstraZeneca’s in ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, ...
The US Food and Drug Administration (FDA) has announced that starting on 1 October 2026, manufacturers must submit adverse ...
Regulatory Focus is the only source of timely, quality news and information fully dedicated to daily online coverage of the global regulation of healthcare products. An experienced team of reporters ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results